IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager
IRLAB Therapeutics AB Logo
IRLAB Therapeutics AB
STO:IRLAB A
Watchlist
Price: 12.6 SEK -1.95% Market Closed
Market Cap: 652.5m SEK
Have any thoughts about
IRLAB Therapeutics AB?
Write Note

Relative Value

The Relative Value of one IRLAB A stock under the Base Case scenario is 16.17 SEK. Compared to the current market price of 12.6 SEK, IRLAB Therapeutics AB is Undervalued by 22%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IRLAB A Relative Value
Base Case
16.17 SEK
Undervaluation 22%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
36
vs Industry
9
Median 3Y
12.6
Median 5Y
11
Industry
2.6
Forward
5.3
vs History
vs Industry
Median 3Y
-3
Median 5Y
-5.6
Industry
22.3
Forward
-7.4
vs History
vs Industry
Median 3Y
-2.9
Median 5Y
-6.2
Industry
17.5
vs History
vs Industry
Median 3Y
-2.8
Median 5Y
-11.6
Industry
24.8
vs History
19
vs Industry
6
Median 3Y
5.3
Median 5Y
5.7
Industry
2.1
vs History
33
vs Industry
9
Median 3Y
9.6
Median 5Y
7.4
Industry
2.7
Forward
4.5
vs History
vs Industry
Median 3Y
-6.9
Median 5Y
0
Industry
5.3
vs History
vs Industry
Median 3Y
-1.8
Median 5Y
-4.9
Industry
13.4
Forward
-6.6
vs History
vs Industry
Median 3Y
-1.8
Median 5Y
-4.9
Industry
16.8
Forward
-6.4
vs History
vs Industry
Median 3Y
-1.8
Median 5Y
-5.3
Industry
15.9
vs History
vs Industry
Median 3Y
-1.8
Median 5Y
-5.3
Industry
18.5
vs History
84
vs Industry
15
Median 3Y
12
Median 5Y
14.9
Industry
1.9

Multiples Across Competitors

IRLAB A Competitors Multiples
IRLAB Therapeutics AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
IRLAB Therapeutics AB
STO:IRLAB A
653.5m SEK 15.7 -5.5 -4.7 -4.7
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
788.6B USD 20.3 107.4 53.8 60.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.4T DKK 13.1 37.5 25 28.7
US
Johnson & Johnson
NYSE:JNJ
384.8B USD 4.4 26.2 12.6 16.5
US
Merck & Co Inc
NYSE:MRK
259.4B USD 4.2 18.9 12.8 15.8
CH
Roche Holding AG
SIX:ROG
213.6B CHF 3.6 18.6 10.4 12.4
UK
AstraZeneca PLC
LSE:AZN
171.2B GBP 4.5 34.3 170.5 255.6
CH
Novartis AG
SIX:NOVN
183.5B CHF 4.3 13.1 10.4 15.4
US
Pfizer Inc
NYSE:PFE
160.4B USD 2.7 37.7 11 16.7
P/E Multiple
Earnings Growth
SE
IRLAB Therapeutics AB
STO:IRLAB A
Average P/E: 36.7
Negative Multiple: -5.5
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
107.4
454%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
37.5
89%
US
Johnson & Johnson
NYSE:JNJ
26.2
-22%
US
Merck & Co Inc
NYSE:MRK
18.9
7 426%
CH
Roche Holding AG
SIX:ROG
18.6
30%
UK
AstraZeneca PLC
LSE:AZN
34.3
175%
CH
Novartis AG
SIX:NOVN
13.1
19%
US
Pfizer Inc
NYSE:PFE
37.7
712%
EV/EBIT Multiple
EBIT Growth
SE
IRLAB Therapeutics AB
STO:IRLAB A
Average EV/EBIT: 2 013.7
Negative Multiple: -4.7
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 046 864.6 N/A
US
Eli Lilly and Co
NYSE:LLY
60.2
212%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
675%
DK
Novo Nordisk A/S
CSE:NOVO B
28.7
85%
US
Johnson & Johnson
NYSE:JNJ
16.5
29%
US
Merck & Co Inc
NYSE:MRK
15.8
695%
CH
Roche Holding AG
SIX:ROG
12.4
27%
UK
AstraZeneca PLC
LSE:AZN
255.6
131%
CH
Novartis AG
SIX:NOVN
15.4
54%
US
Pfizer Inc
NYSE:PFE
16.7
63%

See Also

Discover More
Back to Top